Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Serological assays for emerging coronaviruses: challenges and pitfalls.

Meyer B, Drosten C, Müller MA.

Virus Res. 2014 Dec 19;194:175-83. doi: 10.1016/j.virusres.2014.03.018. Epub 2014 Mar 23. Review.

PMID:
24670324
2.

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.

Agnihothram S, Gopal R, Yount BL Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS.

J Infect Dis. 2014 Apr 1;209(7):995-1006. doi: 10.1093/infdis/jit609. Epub 2013 Nov 18.

3.
4.

From SARS coronavirus to novel animal and human coronaviruses.

To KK, Hung IF, Chan JF, Yuen KY.

J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8. doi: 10.3978/j.issn.2072-1439.2013.06.02.

5.
6.

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.

Patrick DM, Petric M, Skowronski DM, Guasparini R, Booth TF, Krajden M, McGeer P, Bastien N, Gustafson L, Dubord J, Macdonald D, David ST, Srour LF, Parker R, Andonov A, Isaac-Renton J, Loewen N, McNabb G, McNabb A, Goh SH, Henwick S, Astell C, Guo JP, Drebot M, Tellier R, Plummer F, Brunham RC.

Can J Infect Dis Med Microbiol. 2006 Nov;17(6):330-6.

7.

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM, Drexler JF, Smits SL, El Tahir YE, De Sousa R, van Beek J, Nowotny N, van Maanen K, Hidalgo-Hermoso E, Bosch BJ, Rottier P, Osterhaus A, Gortázar-Schmidt C, Drosten C, Koopmans MP.

Lancet Infect Dis. 2013 Oct;13(10):859-66. doi: 10.1016/S1473-3099(13)70164-6. Epub 2013 Aug 9.

PMID:
23933067
8.

Bat origin of human coronaviruses.

Hu B, Ge X, Wang LF, Shi Z.

Virol J. 2015 Dec 22;12:221. doi: 10.1186/s12985-015-0422-1. Review.

10.

Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers.

Tan YJ, Goh PY, Fielding BC, Shen S, Chou CF, Fu JL, Leong HN, Leo YS, Ooi EE, Ling AE, Lim SG, Hong W.

Clin Diagn Lab Immunol. 2004 Mar;11(2):362-71.

11.

Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.

Al-Tawfiq JA, Zumla A, Memish ZA.

Curr Opin Infect Dis. 2014 Oct;27(5):411-7. doi: 10.1097/QCO.0000000000000089. Review.

PMID:
25033169
12.

Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS.

Drexler JF, Corman VM, Drosten C.

Antiviral Res. 2014 Jan;101:45-56. doi: 10.1016/j.antiviral.2013.10.013. Epub 2013 Oct 31. Review.

PMID:
24184128
13.

Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China.

He B, Zhang Y, Xu L, Yang W, Yang F, Feng Y, Xia L, Zhou J, Zhen W, Feng Y, Guo H, Zhang H, Tu C.

J Virol. 2014 Jun;88(12):7070-82. doi: 10.1128/JVI.00631-14. Epub 2014 Apr 9.

14.

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.

Hilgenfeld R, Peiris M.

Antiviral Res. 2013 Oct;100(1):286-95. doi: 10.1016/j.antiviral.2013.08.015. Epub 2013 Sep 6. Review.

PMID:
24012996
15.

Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA.

Corman VM, Ölschläger S, Wendtner CM, Drexler JF, Hess M, Drosten C.

J Clin Virol. 2014 Jun;60(2):168-71. doi: 10.1016/j.jcv.2014.03.012. Epub 2014 Mar 28.

PMID:
24726679
16.

Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.

He Q, Manopo I, Lu L, Leung BP, Chng HH, Ling AE, Chee LL, Chan SW, Ooi EE, Sin YL, Ang B, Kwang J.

Clin Diagn Lab Immunol. 2005 Feb;12(2):321-8.

17.

Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.

Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY.

Lancet. 2004 Mar 13;363(9412):841-5.

PMID:
15031027
18.

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.

Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y.

Virol J. 2013 Aug 26;10:266. doi: 10.1186/1743-422X-10-266.

19.

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.

Müller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R, Bestebroer TM, Specht S, Suliman T, Zimmermann K, Binger T, Eckerle I, Tschapka M, Zaki AM, Osterhaus AD, Fouchier RA, Haagmans BL, Drosten C.

MBio. 2012 Dec 11;3(6). pii: e00515-12. doi: 10.1128/mBio.00515-12.

20.

A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

Du L, Zhao G, Yang Y, Qiu H, Wang L, Kou Z, Tao X, Yu H, Sun S, Tseng CT, Jiang S, Li F, Zhou Y.

J Virol. 2014 Jun;88(12):7045-53. doi: 10.1128/JVI.00433-14. Epub 2014 Apr 9.

Supplemental Content

Support Center